Related references
Note: Only part of the references are listed.Toll-Like Receptors and Relevant Emerging Therapeutics with Reference to Delivery Methods
Nasir Javaid et al.
PHARMACEUTICS (2019)
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
Ronaldo A. Ribeiro et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Eritoran Suppresses Colon Cancer by Altering a Functional Balance in Toll-like Receptors That Bind Lipopolysaccharide
Wei-Ting Kuo et al.
CANCER RESEARCH (2016)
Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4
Jean-Franois Llitjos et al.
JOURNAL OF PATHOLOGY (2016)
CD14/TLR4 priming potentially recalibrates and exerts anti-tumor efficacy in tumor associated macrophages in a mouse model of pancreatic carcinoma
Hridayesh Prakash et al.
SCIENTIFIC REPORTS (2016)
TLR7-based cancer immunotherapy decreases intratumoral myeloid-derived suppressor cells and blocks their immunosuppressive function
Thibaud Spinetti et al.
ONCOIMMUNOLOGY (2016)
Inhibition of induced nitric oxide synthase enhances the anti-tumor effects on cancer immunotherapy using TLR7 agonist in mice
Hiroyasu Ito et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer
Tanja Grimmig et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer
Xiyu Liu et al.
TUMOR BIOLOGY (2015)
Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer
Yun Luo et al.
ONCOTARGET (2015)
TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells
Dayson Moreira et al.
ONCOTARGET (2015)
TLR7 Promotes Tumor Progression, Chemotherapy Resistance, and Poor Clinical Outcomes in Non-Small Cell Lung Cancer
Saradiya Chatterjee et al.
CANCER RESEARCH (2014)
TLR4 is essential for dendritic cell activation and anti-tumor T-cell response enhancement by DAMPs released from chemically stressed cancer cells
Hongliang Fang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2014)
Role of Toll-like receptors in cervical, endometrial and ovarian cancers: A review
Nader Husseinzadeh et al.
GYNECOLOGIC ONCOLOGY (2014)
Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer
Laure Belmont et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer
Hui Zhou et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2
Chaoguang Xin et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
MAP1S Controls Breast Cancer Cell TLR5 Signaling Pathway and Promotes TLR5 Signaling-based Tumor Suppression
Ming Shi et al.
PLOS ONE (2014)
Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis
V. Damiano et al.
BRITISH JOURNAL OF CANCER (2013)
TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence
Ilana Chefetz et al.
CELL CYCLE (2013)
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
Aurelie Couturier-Maillard et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Tumor-Produced Versican V1 Enhances hCAP18/LL-37 Expression in Macrophages through Activation of TLR2 and Vitamin D3 Signaling to Promote Ovarian Cancer Progression In Vitro
Dong Li et al.
PLOS ONE (2013)
Flagellin enhances tumor-specific CD8+ T cell immune responses through TLR5 stimulation in a therapeutic cancer vaccine model
Chung Truong Nguyen et al.
VACCINE (2013)
Activation of TLR4 signaling promotes gastric cancer progression by inducing mitochondrial ROS production
X. Yuan et al.
CELL DEATH & DISEASE (2013)
Toll-like receptors gene polymorphisms may confer increased susceptibility to breast cancer development
George E. Theodoropoulos et al.
BREAST (2012)
Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
Dianne H. Dapito et al.
CANCER CELL (2012)
Roles of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of human prostate cancer cells
Nanae Harashima et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Treatment With OPN-305, a Humanized Anti-Toll-Like Receptor-2 Antibody, Reduces Myocardial Ischemia/Reperfusion Injury in Pigs
Fatih Arslan et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2012)
Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer
Albert S. Baldwin
IMMUNOLOGICAL REVIEWS (2012)
The application of Toll like receptors for cancer therapy
Eui Young So et al.
International Journal of Biological Sciences (2012)
The toll-like receptor 2 (TLR2)-196 to-174 del/ins polymorphism affects viral loads and susceptibility to hepatocellular carcinoma in chronic hepatitis C
Hans-Dieter Nischalke et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Toll-like Receptor 5 Agonist Protects Mice From Dermatitis and Oral Mucositis Caused by Local Radiation: Implications for Head-and-Neck Cancer Radiotherapy
Lyudmila G. Burdelya et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Profound impact of gut homeostasis on chemically-induced pro-tumorigenic inflammation and hepatocarcinogenesis in rats
Hui-Lu Zhang et al.
JOURNAL OF HEPATOLOGY (2012)
Polyinosinic-Polycytidylic Acid Limits Tumor Outgrowth in a Mouse Model of Metastatic Lung Cancer
Giovanni Forte et al.
JOURNAL OF IMMUNOLOGY (2012)
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Sergei I. Grivennikov et al.
NATURE (2012)
Anticancer TLR agonists on the ropes
Malini Guha
NATURE REVIEWS DRUG DISCOVERY (2012)
Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation
Joseph M. Reynolds et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Simultaneous Targeting of Toll- and Nod-Like Receptors Induces Effective Tumor-Specific Immune Responses
Johan Garaude et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Targeting pattern recognition receptors in cancer immunotherapy
Nadege Goutagny et al.
TARGETED ONCOLOGY (2012)
CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production
Xiaoli Li et al.
TUMOR BIOLOGY (2012)
Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses
Francesc Rudilla et al.
VACCINE (2012)
Trial Watch Experimental Toll-like receptor agonists for cancer therapy
Lorenzo Galluzzi et al.
ONCOIMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Expression of Toll-Like Receptors on Breast Tumors: Taking a Toll on Tumor Microenvironment
Debika Bhattacharya et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Inhibition and promotion of tumor growth with adeno-associated virus carcinoembryonic antigen vaccine and Toll-like receptor agonists
P. L. Triozzi et al.
CANCER GENE THERAPY (2011)
Adjuvant effect of a natural TLR4 ligand on dendritic cell-based cancer immunotherapy
Jee Youn Kim et al.
CANCER LETTERS (2011)
Activation of Toll-like Receptor 5 on Breast Cancer Cells by Flagellin Suppresses Cell Proliferation and Tumor Growth
Zhenyu Cai et al.
CANCER RESEARCH (2011)
LPS-Induced TLR4 Signaling in Human Colorectal Cancer Cells Increases β1 Integrin-Mediated Cell Adhesion and Liver Metastasis
Rich Y. C. Hsu et al.
CANCER RESEARCH (2011)
Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
Hailing Lu et al.
CLINICAL CANCER RESEARCH (2011)
Intratumoral Administration of TLR4 Agonist Absorbed into a Cellular Vector Improves Antitumor Responses
Meghan B. Davis et al.
CLINICAL CANCER RESEARCH (2011)
High mobility group box-1 protein regulate immunosuppression of regulatory T cells through toll-like receptor 4
Xiao-Mei Zhu et al.
CYTOKINE (2011)
EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2011)
Effects of Toll-like receptor signals in T-cell neoplasms
Cori Morrison et al.
FUTURE ONCOLOGY (2011)
Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses
Mohamed Labib Salem
IMMUNOLOGY LETTERS (2011)
Mycobacterium tuberculosis Lipoproteins Directly Regulate Human Memory CD4+ T Cell Activation via Toll-Like Receptors 1 and 2
Christina L. Lancioni et al.
INFECTION AND IMMUNITY (2011)
TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
Yi Zhang et al.
JOURNAL OF IMMUNOLOGY (2011)
Engineering Dendritic Cells to Enhance Cancer Immunotherapy
Jeanette E. Boudreau et al.
MOLECULAR THERAPY (2011)
Synbiotics in Health and Disease
Sofia Kolida et al.
ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 2 (2011)
When Toll-like receptor and T-cell receptor signals collide: a mechanism for enhanced CD8 T-cell effector function
Degui Geng et al.
BLOOD (2010)
Amplifying TLR-MyD88 Signals within Tumor-Specific T Cells Enhances Antitumor Activity to Suboptimal Levels of Weakly Immunogenic Tumor Antigens
Degui Geng et al.
CANCER RESEARCH (2010)
Toll-like Receptor 3-Mediated Suppression of TRAMP Prostate Cancer Shows the Critical Role of Type I Interferons in Tumor Immune Surveillance
Arnold I. Chin et al.
CANCER RESEARCH (2010)
Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
Chiara Brignole et al.
CANCER RESEARCH (2010)
TLR3 induction by anticancer drugs potentiates poly I:C-induced tumor cell apoptosis
Manabu Taura et al.
CANCER SCIENCE (2010)
Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats
Richard K. Le Leu et al.
CARCINOGENESIS (2010)
Endotoxin Accumulation Prevents Carcinogen-Induced Apoptosis and Promotes Liver Tumorigenesis in Rodents
Le-Xing Yu et al.
HEPATOLOGY (2010)
Toll-like Receptor 2 Signaling in CD4+ T Lymphocytes Promotes T Helper 17 Responses and Regulates the Pathogenesis of Autoimmune Disease
Joseph M. Reynolds et al.
IMMUNITY (2010)
TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice
Jose M. Gonzalez-Navajas et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance
Julien Cherfils-Vicini et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion
Huan Yang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Cutting Edge: Priming of CD8 T Cell Immunity to Herpes Simplex Virus Type 1 Requires Cognate TLR3 Expression In Vivo
Gayle M. Davey et al.
JOURNAL OF IMMUNOLOGY (2010)
NF-κB and cancer: how intimate is this relationship
Sahdeo Prasad et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2010)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Rifaximin Treatment in Hepatic Encephalopathy
Nathan M. Bass et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bacteria Peptidoglycan Promoted Breast Cancer Cell Invasiveness and Adhesiveness by Targeting Toll-Like Receptor 2 in the Cancer Cells
Wenjie Xie et al.
PLOS ONE (2010)
Topical Imiquimod or Fluorouracil Therapy for Basal and Squamous Cell Carcinoma
W. Elliot Love et al.
ARCHIVES OF DERMATOLOGY (2009)
Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells
Wenjie Xie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Human plasmacytoid dendritic cells are unresponsive to bacterial stimulation and require a novel type of cooperation with myeloid dendritic cells for maturation
Diego Piccioli et al.
BLOOD (2009)
Toll-like receptor expression in normal ovary and ovarian tumors
Mingfu Zhou et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
PUMA is directly activated by NF-kappa B and contributes to TNF-alpha-induced apoptosis
P. Wang et al.
CELL DEATH AND DIFFERENTIATION (2009)
Direct recognition of LPS by human but not murine CD8+ T cells via TLR4 complex
Mousa Komai-Koma et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
The contribution of direct TLR signaling to T cell responses
Adeeb H. Rahman et al.
IMMUNOLOGIC RESEARCH (2009)
Toll-like receptors and the tendency of normal mucous membrane to transform to polyp or colorectal cancer
I. Niedzielska et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Locally Administered TLR7 Agonists Drive Systemic Antitumor Immune Responses That Are Enhanced by Anti-CD40 Immunotherapy
Steve A. Broomfield et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR2 Engagement on CD8 T Cells Enables Generation of Functional Memory Cells in Response to a Suboptimal TCR Signal
Blandine C. Mercier et al.
JOURNAL OF IMMUNOLOGY (2009)
Lipopolysaccharide (LPS) Increases the Invasive Ability of Pancreatic Cancer Cells Through the TLR4/MyD88 Signaling Pathway
Mio Ikebe et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer
M. Szajnik et al.
ONCOGENE (2009)
Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma
Geoffrey W. Stone et al.
PLOS ONE (2009)
TLR9 Signaling Promotes Tumor Progression of Human Lung Cancer Cell In Vivo
Tao Ren et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
The TLR3 agonist poly(I:C) targets CD8+T cells and augments their antigen-specific responses upon their adoptive transfer into naive recipient mice
Mohamed L. Salem et al.
VACCINE (2009)
HMGB1 Mediates Endogenous TLR2 Activation and Brain Tumor Regression
James F. Curtin et al.
PLOS MEDICINE (2009)
Toll-like receptor 3 triggers apoptosis of human prostate cancer cells through a PKC-α-dependent mechanism
Alessio Paone et al.
CARCINOGENESIS (2008)
Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
Nicole Asprodites et al.
FASEB JOURNAL (2008)
Toll-like receptors and adaptor molecules in liver disease: Update
Ekihiro Seki et al.
HEPATOLOGY (2008)
Phase 1 evaluation of intralesionally injected TLR9-agonist PF-3512676 in patients with basal cell carcinoma or metastatic melanoma
Maja A. Hofmann et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
Role of Toll-like receptors in gastrointestinal malignancies
M. Fukata et al.
ONCOGENE (2008)
An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models
Lyudmila G. Burdelya et al.
SCIENCE (2008)
TLR9 engagement on CD4 T lymphocytes represses γ-radiation-induced apoptosis through activation of checkpoint kinase response elements
Liqin Zheng et al.
BLOOD (2008)
Guideline for the management of nonmuscle invasive bladder cancer (Stages Ta, T1, and Tis): 2007 update
M. Craig Hall et al.
JOURNAL OF UROLOGY (2007)
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors
Masayuki Fukata et al.
GASTROENTEROLOGY (2007)
Toll-like receptor 2 -196 to 174del polymorphism influences the susceptibility of Japanese people to gastric cancer
Tomomitsu Tahara et al.
CANCER SCIENCE (2007)
Functional expression of TLR9 is associated to the metastatic potential of human lung cancer cell - Functional active role of TLR9 on tumor metastasis
Tao Ren et al.
CANCER BIOLOGY & THERAPY (2007)
Therapeutic effects of TAK-242, a novel selective Toll-like receptor 4 signal transduction inhibitor, in mouse endotoxin shock model
Takukyu Sha et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
On the discovery of interferon-inducible, double-stranded RNA activated enzymes: The 2'-5'oligoadenylate synthetases and the protein kinase PKR
Ara G. Hovanessian
CYTOKINE & GROWTH FACTOR REVIEWS (2007)
Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8
Tao Lan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The context of epitope presentation can influence functional quality of recalled influenza A virus-specific memory CD8+ T cells
E. Bridie Day et al.
JOURNAL OF IMMUNOLOGY (2007)
Toll-like receptor 3 expressed by melanoma cells as a target for therapy?
Bruno Salaun et al.
CLINICAL CANCER RESEARCH (2007)
Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
Guangyong Peng et al.
IMMUNITY (2007)
Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production
Willscott E. Naugler et al.
SCIENCE (2007)
Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets
Diego Piccioli et al.
BLOOD (2007)
TLR3 ligand stimulates fully functional memory CD8+ T cells in the absence of CD4+ T-cell help
Sandra Hervas-Stubbs et al.
BLOOD (2007)
Differential regulation and properties of MAPKs
M. Raman et al.
ONCOGENE (2007)
Integrating signals from RTKs to ERK/MAPK
M. M. McKay et al.
ONCOGENE (2007)
Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro
Joanna M. Ilvesaro et al.
PROSTATE (2007)
Development of TLR9 agonists for cancer therapy
Arthur M. Krieg
JOURNAL OF CLINICAL INVESTIGATION (2007)
TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance
Weigang He et al.
MOLECULAR IMMUNOLOGY (2007)
TLR ligands act directly upon T cells to restore proliferation in the absence of protein kinase C-θ signaling and promote autoimmune myocarditis
Benjamin J. Marsland et al.
JOURNAL OF IMMUNOLOGY (2007)
Plasmacytoid dendritic cells synergize with myeloid dendritic cells in the induction of antigen-specific antitumor immune responses
Yanyan Lou et al.
JOURNAL OF IMMUNOLOGY (2007)
TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell
Elise Chiffoleau et al.
INTERNATIONAL IMMUNOLOGY (2007)
Role of dioxin response element and nuclear factor-kappa B motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of fas and fas ligand expression
Narendra P. Singh et al.
MOLECULAR PHARMACOLOGY (2007)
The JNK signal transduction pathway
Claire R. Weston et al.
CURRENT OPINION IN CELL BIOLOGY (2007)
RIP1, a kinase on the crossroads of a cell's decision to live or die
N. Festjens et al.
CELL DEATH AND DIFFERENTIATION (2007)
Phase II trial of a Toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma
Mikhail Pashenkov et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor
Julie Tabiasco et al.
JOURNAL OF IMMUNOLOGY (2006)
Effects of LPS-mediated bystander activation in the innate immune system
Rajwardhan Yadav et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression
D. S. Basseres et al.
ONCOGENE (2006)
Contribution of interferon-β to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide
Karen E. Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Imiquimod in the treatment of lentigo maligna
S. F. Rajpar et al.
BRITISH JOURNAL OF DERMATOLOGY (2006)
Functions of the MAPK family in vertebrate-development
S. F. Gabby Krens et al.
FEBS LETTERS (2006)
Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer
T. Boraska Jelavic et al.
CLINICAL GENETICS (2006)
Gamma interferon secretion by human Vγ2Vδ2 T cells after stimulation with antibody against the T-cell receptor plus the Toll-like receptor 2 agonist Pam3Cys
Carl O. Deetz et al.
INFECTION AND IMMUNITY (2006)
TLR2 engagement on CD8 T cells lowers the threshold for optimal antigen-induced T cell activation
Anne Cottalorda et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Continuous ERK activation downregulates anti proliferative genes throughout G1 phase to allow cell-cycle progression
Takuya Yamamoto et al.
CURRENT BIOLOGY (2006)
Antitumor activity of the TLR-5 ligand flagellin in mouse models of cancer
Lucia Sfondrini et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells
HY Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Signals from within:: the DNA-damage-induced NF-κB response
S Janssens et al.
CELL DEATH AND DIFFERENTIATION (2006)
TLR3 can directly trigger apoptosis in human cancer cells
Bruno Salaun et al.
JOURNAL OF IMMUNOLOGY (2006)
NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-κB activation
CJ Wu et al.
NATURE CELL BIOLOGY (2006)
Cutting edge: Diminished T cell TLR expression and function modulates the immune response in human filarial infection
Subash Babu et al.
JOURNAL OF IMMUNOLOGY (2006)
TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer
MG Kelly et al.
CANCER RESEARCH (2006)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Direct costimulatory effect of TLR3 ligand poly(I:C) on human γδ T lymphocytes
D Wesch et al.
JOURNAL OF IMMUNOLOGY (2006)
Toll-like receptor 2 controls expansion and function of regulatory T cells
RPM Sutmuller et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Interplay between PI3K/Akt and MAPK signaling pathways in DNA-damaging drug-induced apoptosis
Eung-Ryoung Lee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)
PIDD mediates NF-κB activation in response to DNA damage
S Janssens et al.
CELL (2005)
Helicobacter pylori-induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase-2 induction through TLR2/TLR9 and promoter regulation
YJ Chang et al.
JOURNAL OF IMMUNOLOGY (2005)
Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells
NK Crellin et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptor 4 in butylated hydroxytoluene-induced mouse pulmonary inflammation and tumorigenesis
AK Bauer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Essential function for the kinase TAK1 in innate and adaptive immune responses
S Sato et al.
NATURE IMMUNOLOGY (2005)
Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cells
XR Hu et al.
LEUKEMIA RESEARCH (2005)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Toll-like, receptor 8-mediated reversal of CD4+ regulatory T cell function
GY Peng et al.
SCIENCE (2005)
Direct stimulation of human T cells via TLR5 and TLR7/8:: Flagellin and R-848 up-regulate proliferation and IFN-γ production by memory CD4+ T cells
G Caron et al.
JOURNAL OF IMMUNOLOGY (2005)
Toll-like receptors-2,-3 and-4 expression patterns on human colon and their regulation by mucosal-associated bacteria
E Furrie et al.
IMMUNOLOGY (2005)
Crystal structure of human Toll-like receptor 3 (TLR3) ectodomain
J Choe et al.
SCIENCE (2005)
Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines
S Bloethner et al.
CARCINOGENESIS (2005)
Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma
S Wei et al.
CANCER RESEARCH (2005)
Toll-like receptors on tumor cells facilitate evasion of immune surveillance (Publication with Expression of Concern. See vol. 79, pg. 4305, 2019)
B Huang et al.
CANCER RESEARCH (2005)
A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease
MM Fort et al.
JOURNAL OF IMMUNOLOGY (2005)
Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88
U Hasan et al.
JOURNAL OF IMMUNOLOGY (2005)
Senescent cells, tumor suppression, and organismal aging: Good citizens, bad neighbors
J Campisi
CELL (2005)
The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling
KL Dunn et al.
BIOCHEMISTRY AND CELL BIOLOGY (2005)
Activation and signaling of the p38 MAP kinase pathway
T Zarubin et al.
CELL RESEARCH (2005)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesis
O Timofeev et al.
CELL CYCLE (2005)
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: Results from two phase III, randomized, vehicle-controlled studies
J Geisse et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
RAS and RHO GTPases in G1-phase cell-cycle regulation
ML Coleman et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
IFN-β induces caspase-mediated apoptosis by disrupting mitochondria in human advanced stage colon cancer cell lines
SH Juang et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2004)
Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB
KJ Campbell et al.
MOLECULAR CELL (2004)
TLR2 is expressed on activated T cells as a costimulatory receptor
M Komai-Koma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model
C Schneider et al.
GUT (2004)
p38 MAP kinase: a convergence point in cancer therapy
JM Olson et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Toll-like receptor control of the adaptive immune responses
A Iwasaki et al.
NATURE IMMUNOLOGY (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Role of urothelial cells in BCG immunotherapy for superficial bladder cancer
RFM Bevers et al.
BRITISH JOURNAL OF CANCER (2004)
Cutting edge: LFA-1 integrin-dependent T cell adhesion is regulated by both ag specificity and sensitivity
KL Mueller et al.
JOURNAL OF IMMUNOLOGY (2004)
Characterization of the murine alpha interferon gene family
V van Pesch et al.
JOURNAL OF VIROLOGY (2004)
The p38 MAP kinase pathway as a therapeutic target in inflammatory disease
J Saklatvala
CURRENT OPINION IN PHARMACOLOGY (2004)
Characterization of the type I interferon locus and identification of novel genes
MP Hardy et al.
GENOMICS (2004)
The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization
K Miyoshi et al.
ONCOGENE (2004)
Cooperative regulation of the cell division cycle by the protein kinases RAF and AKT
AM Mirza et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation
N Kobayashi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease
V Sobek et al.
ARTHRITIS RESEARCH & THERAPY (2004)
Dendritic cell infiltration and prognosis of early stage breast cancer
I Treilleux et al.
CLINICAL CANCER RESEARCH (2004)
A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration
LO Murphy et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Oscillations in NF-κB signaling control the dynamics of gene expression
DE Nelson et al.
SCIENCE (2004)
Toll-like receptor ligands directly promote activated CD4+ T cell survival
AE Gelman et al.
JOURNAL OF IMMUNOLOGY (2004)
Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells
SM Kaech et al.
NATURE IMMUNOLOGY (2003)
Imiquimod in basal cell carcinoma: how does it work?
R Dummer et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
CK2 is a C-terminal IκB kinase responsible for NF-κB activation during the UV response
T Kato et al.
MOLECULAR CELL (2003)
Role of the p38 MAPK pathway in cisplatin-based therapy
JH Losa et al.
ONCOGENE (2003)
Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma
K Iyoda et al.
CANCER (2003)
T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors
A Zanin-Zhorov et al.
FASEB JOURNAL (2003)
Role of Jun and Jun kinase in resistance of cancer cells to therapy
I Vasilevskaya et al.
DRUG RESISTANCE UPDATES (2003)
Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of gadd45a
DV Bulavin et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
p38 mitogen-activated protein kinase mediates cell death and p21-activated kinase mediates cell survival during chemotherapeutic drug-induced mitotic arrest
K Deacon et al.
MOLECULAR BIOLOGY OF THE CELL (2003)
Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis
M Chawla-Sarkar et al.
APOPTOSIS (2003)
Plasmacytoid dendritic cells prime IFN-γ-secreting melanoma-specific CD8 lymphocytes and are found in primary melanoma lesions
M Salio et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activation
GM Hur et al.
GENES & DEVELOPMENT (2003)
Toll-like receptor 3 mediates a more potent antiviral response than toll-like receptor 4
SE Doyle et al.
JOURNAL OF IMMUNOLOGY (2003)
Suppression of Ras-stimulated transformation by the JNK signal transduction pathway
NJ Kennedy et al.
GENES & DEVELOPMENT (2003)
Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide
I Caramalho et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53
R Eferl et al.
CELL (2003)
Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation
A Boonstra et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
I kappa B kinase-independent I kappa Ba degradation pathway: Functional NF-kappa B activity and implications for cancer therapy
V Tergaonkar et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion
JH Harmey et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice
E Seki et al.
JOURNAL OF IMMUNOLOGY (2002)
Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model
K Heckelsmiller et al.
JOURNAL OF IMMUNOLOGY (2002)
Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformation
K Pruitt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Interferon-α and interleukin-12 are induced differentially by toll-like receptor 7 ligands in human blood dendritic cell subsets
T Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
NF-κB-mediated up-regulation of Bcl-XS and Bax contributes to cytochrome c release in cyanide-induced apoptosis
Y Shou et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Mouse and human dendritic cell subtypes
K Shortman et al.
NATURE REVIEWS IMMUNOLOGY (2002)
IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development
YX Cao et al.
CELL (2001)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
WP Zou et al.
NATURE MEDICINE (2001)
Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus
P Blanco et al.
SCIENCE (2001)
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
L Alexopoulou et al.
NATURE (2001)
Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
N Kadowaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
NF-κB activation results in rapid inactivation of JNK in TNFα-treated Ewing sarcoma cells:: a mechanism for the anti-apoptotic effect of NF-κB
D Javelaud et al.
ONCOGENE (2001)
Involvement of trail/trail-R interaction in IFN-α-induced apoptosis of daudi B lymphoma cells
K Oshima et al.
CYTOKINE (2001)
Progress in human tumour immunology and immunotherapy
SA Rosenberg
NATURE (2001)
Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
JM Kyriakis et al.
PHYSIOLOGICAL REVIEWS (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
IFN-β induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7
J Sancéau et al.
ONCOGENE (2000)
Induction of Fas ligand-mediated apoptosis by interferon-α
KA Kirou et al.
CLINICAL IMMUNOLOGY (2000)
The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products
A Bowie et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2000)
Share Paper
